Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Jeff Collins will serve as a judge in the Commercializing Innovation competition at the Wake Forest Business School in Winston-Salem, NC
News | 04. 24. 2008
